Globus Medical (GMED) vs West Pharmaceutical Services (WST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
West Pharmaceutical Services (WST) has outperformed Globus Medical (GMED) over the past year, gaining 35.6% versus a gain of 21.4%. Over five years, GMED leads with a -4.1% price change compared with -10.3% for WST. West Pharmaceutical Services is the larger company by market cap ($25.96 billion vs $10.06 billion), about 2.6 times the size, while Globus Medical is growing revenue faster (+16.7% vs +6.3%).
On valuation, Globus Medical trades at a lower forward P/E (13.9x vs 36.9x for West Pharmaceutical Services). West Pharmaceutical Services pays a dividend yielding 0.24%, while Globus Medical does not currently pay one. Globus Medical converts more of its revenue into profit, with a net margin of 18.3% versus 16.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GMED | WST |
|---|---|---|
| Share price | $74.91 | $368.88 |
| Market cap | $10.06B | $25.96B |
| 1-day change | +2.15% | +1.54% |
| YTD return | -16.01% | +32.03% |
| 1-year return | +21.37% | +35.58% |
| 5-year return | -4.06% | -10.26% |
| P/E ratio (TTM) | 19.21 | 47.23 |
| Forward P/E | 13.88 | 36.91 |
| EPS (TTM) | $3.90 | $7.81 |
| Dividend yield | 0.00% | 0.24% |
| Annual dividend | $0.00 | $0.87 |
| Revenue (latest FY) | $2.94B | $3.07B |
| Revenue growth (YoY) | +16.65% | +6.25% |
| Net income (latest FY) | $537.87M | $493.70M |
| Gross margin | 67.41% | 35.91% |
| Operating margin | 16.33% | 19.03% |
| Net margin | 18.30% | 16.06% |
| 52-week high | $101.40 | $386.00 |
| 52-week low | $56.50 | $223.83 |
| Distance from 52-week high | -26.12% | -4.44% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +34.72% | +11.42% |
| Average volume | 1.51M | 625.67K |
| Shares outstanding | 111.83M | 70.38M |
| Employees | 6,000 | 10,800 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- West Pharmaceutical Services is about 2.6 times larger than Globus Medical by market value ($25.96B vs $10.06B).
- WST has outperformed GMED by 14.2 percentage points over the past year.
- West Pharmaceutical Services trades at a higher earnings multiple (47.2x vs 19.2x trailing P/E).
- Globus Medical grew revenue faster in its latest fiscal year (+16.65% vs +6.25%).
About Globus Medical
GMED stock →Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 6,000 employees
About West Pharmaceutical Services
WST stock →West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 10,800 employees
GMED vs WST FAQ
Which is bigger, Globus Medical or West Pharmaceutical Services?
West Pharmaceutical Services (WST) is larger, with a market capitalization of $25.96B compared with $10.06B for Globus Medical (GMED).
Which stock has performed better over the past year, GMED or WST?
WST returned +35.58% over the past 12 months, compared with +21.37% for GMED (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, GMED or WST?
GMED has the lower trailing P/E at 19.2, versus 47.2 for WST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Globus Medical or West Pharmaceutical Services?
West Pharmaceutical Services pays a dividend yielding 0.24%, while Globus Medical does not currently pay a regular dividend.
Are Globus Medical and West Pharmaceutical Services in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.